Tekla Healthcare Return On Equity vs. Shares Owned By Insiders

HQH Stock  USD 18.68  0.25  1.36%   
Based on the measurements of profitability obtained from Tekla Healthcare's financial statements, Tekla Healthcare Investors is yielding more profit at this time then in previous quarter. It has a moderate probability of reporting better profitability numbers in December. Profitability indicators assess Tekla Healthcare's ability to earn profits and add value for shareholders.
 
Return On Equity  
First Reported
2010-12-31
Previous Quarter
0.0696
Current Value
0.0754
Quarterly Volatility
0.15497738
 
Credit Downgrade
 
Yuan Drop
 
Covid
The current Price To Sales Ratio is estimated to decrease to 14.45. The current Days Sales Outstanding is estimated to decrease to 47.03. As of now, Tekla Healthcare's Operating Income is increasing as compared to previous years. The Tekla Healthcare's current Net Interest Income is estimated to increase to about 748.7 K, while Income Before Tax is projected to decrease to under 48.6 M.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.740.73
Fairly Up
Pretty Stable
For Tekla Healthcare profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Tekla Healthcare to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Tekla Healthcare Investors utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Tekla Healthcare's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Tekla Healthcare Investors over time as well as its relative position and ranking within its peers.
  
Check out Risk vs Return Analysis.
Is Asset Management & Custody Banks space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tekla Healthcare. If investors know Tekla will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tekla Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.145
Dividend Share
1.66
Earnings Share
1.31
Revenue Per Share
0.197
Quarterly Revenue Growth
(0.06)
The market value of Tekla Healthcare Inv is measured differently than its book value, which is the value of Tekla that is recorded on the company's balance sheet. Investors also form their own opinion of Tekla Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Tekla Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tekla Healthcare's market value can be influenced by many factors that don't directly affect Tekla Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tekla Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tekla Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tekla Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Tekla Healthcare Inv Shares Owned By Insiders vs. Return On Equity Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Tekla Healthcare's current stock value. Our valuation model uses many indicators to compare Tekla Healthcare value to that of its competitors to determine the firm's financial worth.
Tekla Healthcare Investors is one of the top stocks in return on equity category among its peers. It is rated below average in shares owned by insiders category among its peers making about  0.10  of Shares Owned By Insiders per Return On Equity. The ratio of Return On Equity to Shares Owned By Insiders for Tekla Healthcare Investors is roughly  10.49 . As of now, Tekla Healthcare's Return On Equity is decreasing as compared to previous years. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Tekla Healthcare's earnings, one of the primary drivers of an investment's value.

Tekla Shares Owned By Insiders vs. Return On Equity

Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Tekla Healthcare

Return On Equity

 = 

Net Income

Total Equity

 = 
0.0734
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.

Tekla Healthcare

Insiders Shares

 = 

Executives Shares

+

Employees

 = 
0.01 %
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.

Tekla Shares Owned By Insiders Comparison

Tekla Healthcare is currently under evaluation in shares owned by insiders category among its peers.

Tekla Healthcare Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Tekla Healthcare, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Tekla Healthcare will eventually generate negative long term returns. The profitability progress is the general direction of Tekla Healthcare's change in net profit over the period of time. It can combine multiple indicators of Tekla Healthcare, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Operating Income64.8 M68 M
Income Before Tax64.8 M48.6 M
Total Other Income Expense Net-3.6 K-3.4 K
Net Income64.8 M48.6 M
Net Income From Continuing Ops50.7 M37.1 M
Net Loss-174.8 M-166.1 M
Income Tax Expense-1.1 M-1.1 M
Interest Income558 K530.1 K
Net Interest Income713 K748.7 K
Change To Netincome-326.9 M-310.6 M
Net Income Per Share 1.31  2.42 
Income Quality(0.73)(0.69)
Net Income Per E B T 0.90  0.80 

Tekla Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Tekla Healthcare. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Tekla Healthcare position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Tekla Healthcare's important profitability drivers and their relationship over time.

Use Tekla Healthcare in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Tekla Healthcare position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tekla Healthcare will appreciate offsetting losses from the drop in the long position's value.

Tekla Healthcare Pair Trading

Tekla Healthcare Investors Pair Trading Analysis

The ability to find closely correlated positions to Tekla Healthcare could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Tekla Healthcare when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Tekla Healthcare - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Tekla Healthcare Investors to buy it.
The correlation of Tekla Healthcare is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Tekla Healthcare moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Tekla Healthcare Inv moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Tekla Healthcare can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Tekla Healthcare position

In addition to having Tekla Healthcare in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Dividend Beast Thematic Idea Now

Dividend Beast
Dividend Beast Theme
An experimental equal-weighted theme of equities with high dividend yield and solid fundamentals based on Macroaxis rating system. The Dividend Beast theme has 68 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Dividend Beast Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Tekla Healthcare Inv offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Tekla Healthcare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Tekla Healthcare Investors Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Tekla Healthcare Investors Stock:
Check out Risk vs Return Analysis.
You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
To fully project Tekla Healthcare's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Tekla Healthcare Inv at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Tekla Healthcare's income statement, its balance sheet, and the statement of cash flows.
Potential Tekla Healthcare investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Tekla Healthcare investors may work on each financial statement separately, they are all related. The changes in Tekla Healthcare's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Tekla Healthcare's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.